8-K: Leidos Q3 Earnings Soar, Full-Year Guidance Raised

Leidos Holdings, Inc. reported strong third-quarter 2025 financial results, including record revenues and increased full-year earnings and margin guidance.

Summary

• Record revenues reached $4.5 billion, marking a 7% increase year-over-year, with 6% attributed to organic growth.
• Net income for the quarter was $369 million, translating to $2.82 per diluted share.
• Adjusted EBITDA (non-GAAP) stood at $616 million, achieving an Adjusted EBITDA margin (non-GAAP) of 13.8%.
• Non-GAAP Diluted Earnings per Share increased 4% year-over-year to $3.05.
• Cash Flows from Operations were robust at $711 million, with Non-GAAP Free Cash Flow at $680 million.
• Net bookings totaled $5.9 billion, resulting in a strong book-to-bill ratio of 1.3.
• Total backlog at the end of the quarter was $47.7 billion, up 5% year-over-year, with funded backlog increasing 27% sequentially to $9.1 billion.
• Leidos raised its fiscal year 2025 guidance for Adjusted EBITDA Margin to 'High 13%' and Non-GAAP Diluted EPS to $11.45 $11.75.

Sentiment

Score: 8

Explanation: The company reported strong financial results across key metrics, including record revenues, increased net income and EPS, and robust cash flow. The significant new contract awards led to a strong book-to-bill ratio and increased backlog. Furthermore, management raised its full-year guidance for earnings and margins and increased the quarterly dividend, indicating confidence in future performance. While some margins slightly decreased and one segment saw a revenue dip, the overall performance and outlook are very positive.

Positives

• Record revenues of $4.47 billion, a 7% increase year-over-year (6% organic growth), driven by increased customer demand for national security and defense solutions.
• Net income increased 2% year-over-year to $369 million, and diluted EPS increased 5% year-over-year to $2.82.
• Adjusted EBITDA increased 3% year-over-year to $616 million, and Non-GAAP diluted EPS increased 4% year-over-year to $3.05.
• Strong cash flow from operations of $711 million and non-GAAP free cash flow of $680 million, driven by strong EBITDA and collections performance.
• Days Sales Outstanding (DSO) for the quarter was 60, indicating efficient cash collection.
• Net bookings of $5.9 billion resulted in a strong book-to-bill ratio of 1.3, signaling future revenue potential.
• Total backlog grew 5% year-over-year to $47.7 billion, with funded backlog up 27% sequentially to $9.1 billion.
• Secured several notable new business awards, including a $2.2 billion classified mission support contract, a $760 million NASA Human Health and Performance subcontract, and a $540 million classified mission software & IT support contract.
• Raised fiscal year 2025 guidance for Adjusted EBITDA Margin to 'High 13%' (from 'Mid 13%') and Non-GAAP Diluted EPS to $11.45 $11.75 (from $11.15 $11.45).
• Increased the quarterly cash dividend by 7.5% to $0.43 per share, payable on December 31, 2025.

Negatives

• Net income margin decreased to 8.3% from 8.6% in the prior year quarter.
• Adjusted EBITDA margin decreased to 13.8% from 14.2% in the prior year quarter.
• Profitability was impacted by a $24 million increase to legal reserves.
• Commercial & International revenues decreased by 1% year-over-year, primarily due to product mix within the security products business.
• National Security & Digital operating income margin decreased modestly to 9.5% from 10.0% in the prior year quarter.
• Defense Systems operating income margin decreased to 6.4% from 7.1% in the prior year quarter, attributed to a higher mix of materials consistent with initial production phases on multiple programs.

Risks

• Developments in U.S. government defense and non-defense budgets, including budget reductions, sequestration, implementation of spending limits, or changes in budgetary priorities.
• Continuation of the U.S. government shutdown and other or future delays in the U.S. government budget process, or the U.S. government's failure to raise the debt ceiling, which increases the possibility of a default by the U.S. government on its debt obligations, related credit-rating downgrades, or an economic recession.
• Uncertainties in tax due to new tax legislation or other regulatory developments.
• Deterioration of economic conditions or weakening in credit or capital markets.
• Uncertainty in the consequences of current and future geopolitical events.
• Inflationary pressures and fluctuations in interest rates.
• Delays in the U.S. government contract procurement process or the award of contracts and delays or loss of contracts as a result of competitor protests.
• Changes in U.S. government procurement rules, regulations, and practices.
• Compliance with various U.S. government and other government procurement rules and regulations.
• Governmental reviews, audits, and investigations of the company.
• Ability to effectively compete and win contracts with the U.S. government and other customers.
• Ability to respond rapidly to emerging technology trends, including the use of artificial intelligence.
• Reliance on information technology spending by hospitals/healthcare organizations.
• Reliance on infrastructure investments by industrial and natural resources organizations.
• Energy efficiency and alternative energy sourcing investments.
• Investments by U.S. government and commercial organizations in environmental impact and remediation projects.
• The effects of an epidemic, pandemic, or similar outbreak may have on the business, financial position, results of operations, and/or cash flows.
• Ability to attract, train, and retain skilled employees, including the management team, and to obtain security clearances for employees.
• Ability to accurately estimate costs, including cost increases due to inflation, associated with firm-fixed-price contracts and other contracts.
• Resolution of legal and other disputes with customers and others or legal or regulatory compliance issues.
• Cybersecurity, data security, or other security threats, system failures, or other disruptions of the business.
• Compliance with international, federal, state, and local laws and regulations regarding privacy, data security, protection, storage, retention, transfer, disposal, and other processing, technology protection, and personal information.
• The damage and disruption to the business resulting from natural disasters and the effects of climate change.
• Ability to effectively acquire businesses and make investments.
• Ability to maintain relationships with prime contractors, subcontractors, and joint venture partners.
• Ability to manage performance and other risks related to customer contracts.
• The failure of inspection or detection systems to detect threats.
• The adequacy of insurance programs, customer indemnifications, or other liability protections designed to protect the company from significant product or other liability claims, including cybersecurity attacks.
• Ability to manage risks associated with international business.
• Ability to comply with the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act of 2010, and similar worldwide anti-corruption and anti-bribery laws and regulations.
• Ability to protect intellectual property and other proprietary rights by third parties of infringement, misappropriation, or other violations by the company of their intellectual property rights.
• Ability to prevail in litigation brought by third parties of infringement, misappropriation, or other violations by the company of their intellectual property rights.
• Ability to declare or increase future dividends based on earnings, financial condition, capital requirements, and other factors, including compliance with applicable law and agreements.
• Ability to grow commercial health and infrastructure businesses, which could be negatively affected by budgetary constraints faced by hospitals and by developers of energy and infrastructure projects.
• Ability to successfully integrate acquired businesses.
• Ability to execute the business plan and long-term management initiatives effectively and to overcome these and other known and unknown risks.

Future Outlook

Leidos is raising its fiscal year 2025 guidance for Adjusted EBITDA Margin to 'High 13%' and Non-GAAP Diluted EPS to $11.45 $11.75, while holding firm on revenue and cash flow guidance. The company is optimistic about its future given its alignment with the priorities of the administration and confidence that customers will move out aggressively in search of smarter and more efficient outcomes for the nation.

Management Comments

• "Leidos continues to deliver exceptional results through the strength of our portfolio of mission-critical work as well as the innovation, agility, and discipline of our talented workforce."
• "Despite the government shutdown, we are raising our 2025 earnings and margin guidance and holding firm on our 2025 revenue and cash guidance."
• "Moreover, we are optimistic about our future given our alignment with the priorities of the administration and confidence that our customers will move out aggressively in search of smarter and more efficient outcomes for the nation."

Industry Context

Leidos operates in the highly competitive government services and technology sector, characterized by significant demand for national security, defense, and digital transformation solutions. The company's strong bookings and backlog growth, particularly in classified mission support and space exploration, indicate its ability to secure large, complex contracts despite potential government shutdowns. The focus on AI-enabled software and modernization aligns with broader industry trends towards advanced digital capabilities and efficiency in government operations. The increase in dividend and share repurchases reflects a mature company with strong cash generation, a common characteristic among established defense and IT contractors.

Comparison to Industry Standards

• Leidos' 7% year-over-year revenue growth (6% organic) is robust for a company of its size in the government contracting space, often outpacing peers who may experience slower growth due to budget constraints or contract cycles.
• A book-to-bill ratio of 1.3 is a strong indicator of future revenue visibility, demonstrating Leidos' ability to win new business at a healthy rate, which is competitive within the defense and government IT sector.
• The increase in funded backlog by 27% sequentially suggests effective conversion of contract awards into funded projects, a key performance metric for government contractors.
• The 7.5% increase in the quarterly dividend reflects confidence in sustained cash flow and profitability, positioning Leidos favorably compared to some industry peers who may maintain static dividends or prioritize debt reduction.
• The company's focus on mission-critical work for national security, defense, and space exploration (NASA) aligns with high-priority government spending areas, potentially offering more stability and growth opportunities than segments reliant on discretionary spending.

Legal Proceedings

• Profitability remained high despite a $24 million increase to legal reserves, indicating ongoing legal matters impacting financial provisions.

Stakeholder Impact

• Shareholders benefit from increased diluted EPS, a 7.5% increase in the quarterly cash dividend, and ongoing share repurchases ($102 million in Q3).
• Customers (primarily government agencies) benefit from Leidos' continued delivery of mission-critical work, innovative products, and solutions for national security, defense, and health missions.
• Employees are recognized for their innovation, agility, and discipline, contributing to the company's exceptional results and securing new contracts.
• Creditors are impacted by term loan principal payments of $450 million in the quarter, reducing overall debt and potentially improving creditworthiness.

Next Steps

• Management will discuss operations and financial results in an earnings conference call on November 4, 2025, at 8:00 a.m. eastern.
• The declared cash dividend of $0.43 per share will be payable on December 31, 2025, to stockholders of record on December 15, 2025.
• Continue to deliver mission-critical work and innovative solutions for national security and defense missions.
• Advance space exploration for low-Earth-orbit and Artemis missions through the NASA Human Health and Performance Contract.
• Enhance and maintain mission-critical, AI-enabled software for Counter Terrorism efforts.
• Modernize Kazakhstan's air traffic control system over a 19-year period.
• Continue to provide operational support and maintain performance stability for the DOD Healthcare Management System Modernization (DHMSM).

Key Dates

Recommendation

Leidos delivered exceptional third-quarter results, exceeding expectations with record revenues and strong growth in net income and EPS. The company's robust cash flow generation, significant new contract wins (evidenced by a 1.3 book-to-bill ratio and substantial backlog growth), and a 7.5% dividend increase demonstrate strong operational performance and financial health. The decision to raise full-year guidance for Adjusted EBITDA Margin and Non-GAAP Diluted EPS, despite a government shutdown, signals management's confidence in sustained profitability and future growth. The company's strategic alignment with high-priority government initiatives, particularly in national security, defense, and advanced technology, positions it well for continued success. These factors collectively present a compelling investment case.

Keywords

Leidos, LDOS, Government Contractor, Defense IT, National Security, Digital Solutions, Health Services, Civil Solutions, Commercial Solutions, International Solutions, Defense Systems, Aerospace, Space Exploration, AI-enabled software, Air Traffic Management, Cybersecurity, Managed Health Services, Q3 2025 Earnings, Financial Results, Guidance Update, Book-to-bill, Backlog, Cash Flow, Dividends, Share Repurchases